Search
for
Sort by
Research 61–90 of 759
- Integrated safety analysis of baricitinib in adults with severe alopecia areata from two randomized clinical trials
- Risk of Safety Events in Vitiligo Patients: A Retrospective Real‐World Data Study in the US
- The Risk of Venous Thromboembolism (VTE) in Men with Benign Prostatic Hyperplasia Treated with 5-Alpha Reductase Inhibitors (5ARIs).
- Cyclin-Dependent Kinase 4/6 Inhibitors and Dermatologic Adverse Events: Results from the EADV Task Force “Dermatology for Cancer Patients” International Study
- Effects Of Hormone Therapy On The Laboratory Profile Of Transgender People: A Scoping Review
- Post-marketing safety signals of four JAK inhibitors for alopecia areata: an indication-restricted FAERS pharmacovigilance study
- Gender‐affirming hormone therapy for transgender and gender‐diverse adults in Australia
- Transgender health and the impact of aging and menopause
- Hormonal Therapies for Acne: A Comprehensive Update for Dermatologists
- Long‐term efficacy and safety of baricitinib in patients with severe alopecia areata: 104‐week results from BRAVE‐AA1 and BRAVE‐AA2
- Ottawa, Ontario, Canada, February 13–16, 2013
- Follikelhormone
- EXPERIENCE WITH ANIFROLUMAB IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS WITH NEUROLOGICAL MANIFESTATIONS
- Peri-operative Antithrombotic Therapy in Hair Transplantation
- Guidelines for perioperative antithrombotic therapy in hair restoration surgery: management of patients with coronary heart disease, mechanical heart valve, and atrial fibrillation
- Rates of Infections, Malignancies, Cardiovascular Outcomes, and Death in Individuals with Hospital-treated Alopecia Areata: A Registry-based Cohort Study in Denmark
- Safety of Biological Therapies for Severe Asthma: An Analysis of Suspected Adverse Reactions Reported in the WHO Pharmacovigilance Database
- BH19 ‘JAK in the box?’ Long-term safety concerns with oral Janus kinase inhibitors for alopecia areata
- Ultra-low dose estradiol and dydrogesterone for the treatment of menopausal symptoms in a pooled, multi-ethnic population
- Central nervous system demyelination associated with tofacitinib use in alopecia areata: A case report and literature review
- Rumpel-Leede Phenomenon Associated with Pneumatic Compression: A Case Report
- Thrombophilia and Polycythemia in a Woman With Budd-Chiari Syndrome
- Topical imiquimod—Be aware of the unexpected
- Polycystic ovary syndrome
- Efficacy and safety of autologous adipose-derived stromal vascular fraction enriched with platelet-rich plasma in flap repair of transsphincteric cryptoglandular fistulas
- Cardiovascular profile of pharmacological agents used for the management of polycystic ovary syndrome
- Fulvestrant, a new treatment option for advanced breast cancer: tolerability versus existing agents
- Efficacy and safety of the oral Janus kinase inhibitor baricitinib in the treatment of adults with alopecia areata: Phase 2 results from a randomized controlled study
- Hormone receptor positive, HER2 negative metastatic breast cancer: Impact of CDK4/6 inhibitors on the current treatment paradigm
- Ritlecitinib in severe alopecia areata: a profile of its use